These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 32572516)
1. [Remdesivir for patients with COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516 [No Abstract] [Full Text] [Related]
2. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
3. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
4. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
5. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. Chua KP; Conti RM JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187 [No Abstract] [Full Text] [Related]
6. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232 [No Abstract] [Full Text] [Related]
7. Treatments for COVID-19: where are we now? Mendes A Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900 [No Abstract] [Full Text] [Related]
8. Repurposing antimalarials and other drugs for COVID-19. Schlagenhauf P; Grobusch MP; Maier JD; Gautret P Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925 [No Abstract] [Full Text] [Related]
9. Uncertainty about the Efficacy of Remdesivir on COVID-19. Yoo JH J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956 [No Abstract] [Full Text] [Related]
10. Experts Discuss COVID-19-Remdesivir, Vaccines, and More. JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002 [No Abstract] [Full Text] [Related]
11. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812 [TBL] [Abstract][Full Text] [Related]
13. Rapid review for the anti-coronavirus effect of remdesivir. Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648 [TBL] [Abstract][Full Text] [Related]
14. [Not Available]. Fumeaux T Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466 [No Abstract] [Full Text] [Related]
15. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge. White DB; Angus DC JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158 [No Abstract] [Full Text] [Related]
16. Audio Interview: New Data on Remdesivir in Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948 [No Abstract] [Full Text] [Related]
18. Use of remdesivir for patients with Covid-19: a review article. Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862 [TBL] [Abstract][Full Text] [Related]
19. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement. Paladugu S; Donato AA Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756 [TBL] [Abstract][Full Text] [Related]